Oculis Holding AG (OCS) Current Assets (2021 - 2026)
Oculis Holding AG (OCS) posted quarterly Current Assets of $289.9 million for Q1 2026, up 38.07% year-over-year from $210.0 million in Q1 2025, and up 5.86% quarter-over-quarter from $273.9 million in Q4 2025.
Oculis Holding AG (OCS) Current Assets (2021 - 2026) Analysis & Trends
Oculis Holding AG's Current Assets history runs 6 years deep, the most recent figure standing at $289.9 million for Q1 2026.
- In Q1 2026, Current Assets rose 38.07% year-over-year to $289.9 million; the TTM figure through Mar 2026 stood at $289.9 million (up 38.07% YoY), while the FY2025 annual figure was $264.0 million, up 121.42% from the prior year.
- Current Assets for Q1 2026 stood at $289.9 million, up from $273.9 million in the prior quarter.
- The five-year high for Current Assets was $289.9 million in Q1 2026, with the low at $24.6 million in Q4 2022.
- The 5-year median for Current Assets is $135.0 million (2023), against an average of $157.8 million.
- The sharpest annual moves came in 2022 and 2023: Current Assets slumped 52.81% in 2022, then jumped 363.75% in 2023.
- Oculis Holding AG's Current Assets stood at $24.6 million in 2022, then soared by 363.75% to $113.9 million in 2023, then increased by 5.15% to $119.7 million in 2024, then soared by 128.71% to $273.9 million in 2025, then rose by 5.86% to $289.9 million in 2026.
- Business Quant data shows OCS's Current Assets at $289.9 million in Q1 2026, $273.9 million in Q4 2025, and $188.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Oculis Holding AG | 879.09 Mn | 590.21 Mn | - | 294.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 294.88 Mn |
| Mar 31, 2026 | 289.93 Mn |
| Dec 31, 2025 | 273.87 Mn |
| Sep 30, 2025 | 188.65 Mn |
| Jun 30, 2025 | 200.75 Mn |
| Mar 31, 2025 | 209.98 Mn |
| Dec 31, 2024 | 119.74 Mn |
| Sep 30, 2024 | 128.68 Mn |
| Jun 30, 2024 | 137.82 Mn |
| Mar 31, 2024 | 97.89 Mn |
| Dec 31, 2023 | 113.88 Mn |
| Sep 30, 2023 | 130.76 Mn |
| Jun 30, 2023 | 134.98 Mn |
| Dec 31, 2022 | 24.56 Mn |
| Dec 31, 2021 | 52.04 Mn |